Table 1

 Baseline patient characteristics

Valsartan (n = 25)Enalapril (n = 25)p Value
Values are mean (SD) or number (%).
BNP, brain natriuretic peptide; CHF, congestive heart failure; DBP, diastolic blood pressure; DCM, dilated cardiomyopathy; H/M, heart to mediastinum count; LVEDV, left ventricular end diastolic volume; LVEF, left ventricular ejection fraction; 123I-MIBG, iodine-123 labelled meta-iodobenzylguanidine; NS, not significant; NYHA, New York Heart Association; OMI, old myocardial infarction; SBP, systolic blood pressure; TDS, total defect score; WR, washout rate.
Age (years)67 (10)68 (9)NS
Height (cm)160 (9)162 (10)NS
Weight (kg)58 (8)59 (9)NS
SBP (mm Hg)132 (16)131 (14)NS
DBP (mm Hg)74 (8)72 (8)NS
NYHA functional class
Cause of CHF
    DCM12 (48%)13 (52%)NS
    OMI8 (32%)9 (36%)NS
    Valve disease5 (20%)3 (12%)NS
    TDS43 (8)43 (9)NS
    H/M ratio1.70 (0.17)1.68 (0.36)NS
    WR46 (11)47 (8)NS
    LVEDV (ml)172 (42)173 (29)NS
    LVEF(%)31 (7)32 (8)NS
Plasma BNP (pg/ml)237 (180)235 (154)NS
Medical treatment
    Loop diuretic25 (100%)25 (100%)NS
    β Blocker15 (60%)17 (68%)NS
    Spironolactone8 (32%)7 (28%)NS
    Nitrate6 (24%)5 (20%)NS
    Calcium antagonist6 (24%)9 (36%)NS
    Digitalis2 (8%)3 (12%)NS